Certified by Founder Lodge
Fore Biotherapeutics
United States - Philadelphia, PA
START UP
1 Disclosed Funding Rounds $75,000,000
0 Participating Investments
-
Founded date
2011
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics. Deeply rooted in science and innovation, our vision is to com
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| August, 25 ,2023 | Series D | $75,000,000 |
OrbiMed
Wellington Management
Novartis
3B Future Health Fund I & II
SR One Capital Management
Medicxi
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
